The Cell & Viral Immunotherapy Events in 2016 are a series of scientific and networking meetings dedicated to accelerate the delivery of the next generations of safe, effective and commercially viable cell and viral immunotherapies. Each targeted event will  gather scientific and business leaders from large pharma, biotech & academia to overcome discovery, development and commercialization challenges affecting the progression of CAR-T, TCR, Tregs, NK & oncolytic virotherapies to patients. Become central in this uniquely collaborative ecosystem.


Through industry-defining content, Hanson Wade events have built focused and senior level networks. We provide our highly valued sponsors more targeted business development, thought leadership and educational opportunities. Bespoke partnerships deliver not only a valuable onsite experience, but also year-round engagement & ultimately outstanding ROI . First time partnerships turn into long standing relationships that offer a genuine value year after year.


Drug developers and manufacturers are constantly innovating and seeking new technologies to position themselves at the forefront of their respective fields. At every conference in the Life Science Community, unpublished data and industry shaping best practice is shared through interactive formats that are complemented by dedicated networking sessions. This is why these meetings are so valued by the industry’s they serve and why they become must-attend events in the calendar.


8076 ADOPT 2017 web banner
hw-neo
hw161213-car-tcr-2017-web-banner
hw-ov
8075 Innate killer 2017 web banner
HW170216 Future Cell Therapy Commercialization Summi banner